Hematology & Oncology Doctors in Columbus, MS Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Wail Alnas, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 345 Baptist Blvd, Columbus, MS 39705 Phone: 662-244-2288    Fax: 662-244-2763

Dr. Karissa Wright Boyd, DO Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2966    Fax: 662-244-2763

John P Whitecar Jr., MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2966    Fax: 662-244-2763

Amber Massey Borden, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2042    Fax: 662-244-2041

News Archive

Study reveals how immune cells are programmed to repair or protect the body

An unexpected finding by an international team of scientists based at The University of Manchester and National Institutes of Health in America has shed new light on how immune cells are programmed to either repair or protect the body.

Men failing to protect eyes from injuries: Experts

A review looking at patients attending a Melbourne hospital's emergency department with a serious eye injury shows that most of them could be prevented by proper eye protection. Men's particular lack of eye protection while using power tools and lawn mowers, usually during routine house maintenance, were the other major factors in the injury cases say the researchers.

Compounds produced by creosote bush exhibit anti-parasitic activity against pathogenic protozoa

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for giardia infections and an amoeba that causes an often-lethal form of encephalitis.

New breakthrough offers hope for potential treatment of rare childhood epilepsy

Seizure disorders in babies are frightening and heartbreaking. A new basic science breakthrough offers hope for a potential treatment for rare developmental and epileptic encephalopathies resulting from a single genetic mutation.

AKP America commences ART-123 Phase 3 trial in severe sepsis patients with coagulopathy

Asahi Kasei Pharma America Corp. today announced the initiation of an 800-patient Phase 3 clinical trial for ART-123 (recombinant human thrombomodulin, marketed as Recomodulin in Japan) in severe sepsis patients with coagulopathy.

Read more Medical News

› Verified 9 days ago